Home Newsfeeds Evercore ISI Group Maintains Outperform on Constellation Brands, Raises Price Target to $260

Evercore ISI Group Maintains Outperform on Constellation Brands, Raises Price Target to $260

Evercore ISI Group analyst Robert Ottenstein maintains Constellation Brands (NYSE:STZ) with a Outperform and raises the price target from $250 to $260.

byBenzinga Newsdesk

January 31, 2023

1 minute read

Evercore ISI Group analyst Robert Ottenstein maintains Constellation Brands (NYSE:STZ) with a Outperform and raises the price target from $250 to $260.

Why Fortinet Stock Is Trading Higher Today

By Erica Kollmann

February 7, 4:13 PM

Wedbush analyst Daniel Ives maintained Fortinet with an Outperform and raised the price target from $75 to $86. Susquehanna analyst Anne Meisner maintained Fortinet with a Neutral and raised the price target from $55 to $80.

FTNT

Thermo Fisher Below Street Expectation, Lowers Annual Guidance Citing ‘Macroeconomic Environment’

By Vandana Singh

July 26, 9:27 AM

Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q2 revenue of $10.69 billion, down 3% Y/Y, missing the

TMO

Drugstore Chain CVS Health’s Move to Simplify Drug Pricing Gives Peek Into FY24 Outlook

By Vandana Singh

December 5, 9:32 AM

CVS Health Corp (NYSE: CVS) announced a new approach called CVS 'CostVantage' that evolves the traditional pharmacy reimbursement model and brings greater transparency and

CVS

EXCLUSIVE: MetAlert Breaks Ground with First Commercial Order of GunAlert from Range USA

By Anusuya Lahiri

October 9, 8:00 AM

MetAlert, Inc (OTC: MLRT) announced through its 100% wholly owned subsidiary Level 2 Security, has received and delivered its first commercial order for the game-changing GunAlert firearm recovery device from Range USA, which has 40+ locations across 10 states and headquartered in Cinci

MLRT

Evercore ISI Group Maintains Outperform on Constellation Brands, Raises Price Target to $260

Related Posts

Why Fortinet Stock Is Trading Higher Today

Thermo Fisher Below Street Expectation, Lowers Annual Guidance Citing ‘Macroeconomic Environment’

Drugstore Chain CVS Health’s Move to Simplify Drug Pricing Gives Peek Into FY24 Outlook

EXCLUSIVE: MetAlert Breaks Ground with First Commercial Order of GunAlert from Range USA